Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women, in vitro diagnostics, acute medical care products, and curative medicines, and information regarding pharmaceuticals and health services, as well as contract manufacturing services. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.
Frequently asked questions
What sector does Fuji Pharma Co Ltd (4554) operate in?
Fuji Pharma Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Fuji Pharma Co Ltd (4554) current stock price?
As of the latest data, Fuji Pharma Co Ltd stock price is ¥1,849, with a previous close of ¥1,864. Fuji Pharma Co Ltd lost -¥15 in the last trading session, representing a -0.8% loss.
What is Fuji Pharma Co Ltd (4554) current market capitalization?
Fuji Pharma Co Ltd market cap is approximately 48.30 billion.
What is Fuji Pharma Co Ltd (4554) Earnings Per Share (EPS)?
The trailing EPS is ¥99, and the forward EPS is ¥211.
What is Fuji Pharma Co Ltd (4554) Price-to-Earnings (P/E) ratio?
Fuji Pharma Co Ltd current P/E ratio is 18.72, with a forward P/E of 8.75.
What is Fuji Pharma Co Ltd (4554) EBITDA?
Fuji Pharma Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 2.05 billion.
Does Fuji Pharma Co Ltd (4554) pay dividends?
Yes. Fuji Pharma Co Ltd pays semiannual dividends with an annualized yield of 2.49% and an estimated annual payout of ¥46 per share.
When is the next ex-dividend date for Fuji Pharma Co Ltd (4554)?
The next ex-dividend date is scheduled for September 30, 2026.
What is Fuji Pharma Co Ltd (4554) beta (volatility) score?
Fuji Pharma Co Ltd has a beta of 0.324, indicating lower volatility than the overall market.
